5th Floor, Rajapushpa Summit
Nanakramguda Rd, Financial District, Gachibowli
Hyderabad, Telangana - 500008
The Spain Artificial Organs & Bionic Implants Market is Segmented by Product (Artificial Organs and Bionics)
2018 - 2026
The Spain Artificial Organs & Bionic Implants Market is expected to grow with a CAGR of 11.64% in the forecast period. The growth of the market in the country can be attributed to the increasing incidence of disabilities and organ failures and increasing medical tourism. Furthermore, the technological advancements in the country are also found to boost the market growth.
Apart from the countries patients, the medical department of Spain treats many other patients as medical tourism is growing its roots in Spain. As the visitors for medical treatment for cardiac and renal surgeries are increasing in number the demand for artificial organs and bionic implants also increases.
As per the scope of the report, artificial organs and bionics are man-made devices that can be implanted or integrated in humans, to either replace a natural organ or provide support for the purpose of restoring specific function or a group of related functions, helping the patient to return to his normal life.
Report scope can be customized per your requirements. Click here.
The cardiac bionics segment is expected to show a high growth that is attributed to the increasing prevalence of cardiovascular diseases, increasing geriatric population in the country that helps in the overall market growth.
According to an article published by Héctor Bueno, Beatriz Pérez-Gómez in the journal Circulation, 2019 edition, stated that cardiovascular disease is the number one cause of death in Spain leading to 120,000 deaths every year. Thus, owing to the large patient pool of cardiac diseases and benefits associated with bionics, the segment is expected to grow over the forecast period.
To understand key trends, Download Sample Report
The Spain Artificial Organs & Bionic Implants Market is moderately competitive with several major players. Some of the strategies implemented include agreements, collaborative models, business expansion, and product developments. Some of the major players in the market include Otto Bock Holding GmbH & Co. KG, Medtronic plc, Sonova Holding AG, Boston Scientific Corporation etc.
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increased Incidence of Disabilities and Organ Failures and Increasing Medical Tourism
4.2.2 Technological Advancements Leading to Enhanced Applications
4.3 Market Restraints
4.3.1 Expensive Procedures and Fear of Device Malfunction and its Consequences
4.4 Porter's Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION
5.1 By Product
5.1.1 Artificial Organs
18.104.22.168 Artificial Heart
22.214.171.124 Artificial Kidney
126.96.36.199 Vision Bionics
188.8.131.52 Ear Bionics
184.108.40.206 Orthopedic Bionic
220.127.116.11 Cardiac Bionics
6. COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Boston Scientific Corporation
6.1.2 Otto Bock Holding GmbH & Co. KG
6.1.3 Medtronic plc
6.1.4 Zimmer Biomet
6.1.5 Sonova Holding AG (Advanced Bionics)
6.1.6 Edwards Lifesciences Corporation
6.1.7 Terumo Medical Corporation
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments